- Home
- AQN vs RNA Comparison
AQN vs RNA Comparison
Compare AQN & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQN
- RNA
- Stock Information
- Founded
- AQN 1988
- RNA 2012
- Country
- AQN Canada
- RNA United States
- Employees
- AQN N/A
- RNA N/A
- Industry
- AQN Electric Utilities: Central
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- AQN Utilities
- RNA Health Care
- Exchange
- AQN Nasdaq
- RNA Nasdaq
- Market Cap
- AQN 4.5B
- RNA 4.0B
- IPO Year
- AQN 1998
- RNA 2020
- Fundamental
- Price
- AQN $5.59
- RNA $69.80
- Analyst Decision
- AQN Hold
- RNA Buy
- Analyst Count
- AQN 6
- RNA 20
- Target Price
- AQN $6.46
- RNA $69.26
- AVG Volume (30 Days)
- AQN 4.2M
- RNA 9.4M
- Earning Date
- AQN 11-07-2025
- RNA 11-07-2025
- Dividend Yield
- AQN 4.65%
- RNA N/A
- EPS Growth
- AQN N/A
- RNA N/A
- EPS
- AQN N/A
- RNA N/A
- Revenue
- AQN $2,378,238,000.00
- RNA $10,729,000.00
- Revenue This Year
- AQN $3.21
- RNA N/A
- Revenue Next Year
- AQN $3.68
- RNA $108.97
- P/E Ratio
- AQN N/A
- RNA N/A
- Revenue Growth
- AQN 2.87
- RNA 1.23
- 52 Week Low
- AQN $4.19
- RNA $21.51
- 52 Week High
- AQN $6.24
- RNA $70.51
- Technical
- Relative Strength Index (RSI)
- AQN 41.08
- RNA 79.37
- Support Level
- AQN $5.46
- RNA $69.50
- Resistance Level
- AQN $5.84
- RNA $69.91
- Average True Range (ATR)
- AQN 0.11
- RNA 1.26
- MACD
- AQN -0.04
- RNA 1.45
- Stochastic Oscillator
- AQN 21.95
- RNA 91.33
About AQN Algonquin Power & Utilities Corp.
Algonquin Power & Utilities Corp is a Canada-based diversified international generation, transmission, and distribution company. The company's operations are organized across two business units consisting of the Regulated Services Group, which owns and operates a portfolio of regulated electric, water distribution and wastewater collection, and natural gas utility systems and transmission operations in the United States, Canada, Bermuda, and Chile; and the Hydro Group, which consists of hydroelectric-generating facilities located in Canada. It generates the majority of its revenue from the Regulated Services Group segment.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.